Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pulse Audition developed AI-powered hearing enhancement glasses (Pulse Frames), using proprietary embedded software for speech isolation and noise reduction, acquired January 2025 by EssilorLuxottica to complement their Nuance Audio line. Clinical performance data not independently published; technology being readied for FDA OTC hearing aid clearance with parent company's rollout.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pulse Audition.